Estimates eGFR using the Full Age Spectrum creatinine equation.
Full Age Spectrum Creatinine eGFR: Clinical Guide
Browse Knowledge HubEstimates eGFR using the Full Age Spectrum creatinine equation.
Overview
Estimates eGFR using the Full Age Spectrum creatinine equation.
Clinical Significance
Requires an appropriate Q value for age, sex and assay.
When to Use
- Use as decision support when all required inputs are reliable.
How It Is Calculated
- eGFR = 107.3/(SCr/Q), multiplied by 0.988^(age−40) after age 40.
Interpretation
- Requires an appropriate Q value for age, sex and assay.
Worked Example
Enter verified values in the displayed units; MedicalC applies the published equation or point system.
Limitations
- Prediction models may be miscalibrated outside their derivation population.
- Measurement and classification error can materially change the result.
Clinical Pearls
- Document source values and units with the result.
- Use trends and the full clinical picture.
Common Mistakes
- Wrong units.
- Using non-contemporaneous inputs.
- Treating the output as a diagnosis or mandatory treatment decision.
Frequently Asked Questions
What does this tool calculate?
Estimates eGFR using the Full Age Spectrum creatinine equation.
Can the result be used alone?
No. Interpret it with the complete clinical assessment and current guidance.
References
- Pottel H et al. Nephrol Dial Transplant. 2016;31:798-806. — Primary or supporting reference for the implemented model.
Reviewed by: MedicalC Clinical Editorial Team
Last reviewed: July 2026
Clinical Disclaimer
MedicalC calculators and clinical tools are intended to support healthcare professionals. They do not replace clinical judgement, individual patient assessment, local guidance or specialist advice.
Results should always be interpreted in the context of the patient’s history, examination, investigations, current clinical condition and applicable professional guidance.
Related clinical knowledge
Explore referenced clinical guidance from the Medical & Dental Professional Development Alliance.
Chronic kidney disease in adults: detection, staging and risk-based management
A clinical reference on CKD detection, staging, kidney failure risk and longitudinal management.
Read on MDPDA ↗Chronic kidney disease-mineral and bone disorder: calcium, phosphate and PTH management
A professional guide to CKD-mineral and bone disorder, including interpretation of calcium, phosphate and PTH, vitamin D, vascular calcification and treatment principles.
Read on MDPDA ↗Diabetic kidney disease: albuminuria, renoprotective therapy and referral
An international guide to diabetic kidney disease, integrating eGFR and albuminuria, renin-angiotensin blockade, SGLT2 inhibition, mineralocorticoid receptor therapy and cardiovascular risk.
Read on MDPDA ↗Acute kidney injury: recognition, cause-directed assessment and renal support
An international clinical guide to acute kidney injury, covering creatinine and urine-output criteria, volume assessment, nephrotoxins, obstruction, electrolyte complications and indications for renal replacement therapy.
Read on MDPDA ↗